Share Buyback

AI learning platform Docebo launches a major share repurchase, betting on its own undervaluation while posting strong growth and navigating a client shift.

Fresh off a massive Moderna settlement, Arbutus Biopharma expands its patent war against Pfizer and plans a $230M shareholder return, a bold strategic move.

SRX Global's plan to buy back up to 50% of its shares is more than a financial maneuver; it's a bold declaration of faith in its AI-driven model.

With its stock lagging, Vermilion Energy renews a major share buyback, a defiant signal of undervaluation. Is this a savvy capital play or a bet against market headwinds?

With its Q2 earnings on deck, Camden Property Trust’s performance offers a crucial look into the health of the multifamily housing market and its strategic shifts.

The RF tech firm's dual move to repurchase shares and terminate its ATM offering signals robust financial health and a strategic pivot to enhance shareholder value.

Highwood Asset Management slashes debt with a major divestiture, fueling a focused strategy on high-margin oil, shareholder buybacks, and a bold new venture into critical minerals.

ING's €1B share buyback is more than a capital return; it's a strategic declaration of strength amid sector-wide trends and a cautious economic outlook.

The energy giant is redeeming preferred units. It's not just housekeeping—it’s a calculated move reflecting deep financial health and a sector-wide shift.

In a landmark move, Strategy Inc. unveils a new capital framework, trading pure conviction for controlled financial engineering. Is this the blueprint for the future?

Wise's stellar FY26 results show more than just growth. They reveal a durable strategy of infrastructure, regulation, and customer value in a volatile market.

ICF boosts its share repurchase program, a move signaling deep confidence. But is it just a shareholder play, or part of a larger strategic vision?

The tech firm is buying back nearly half its shares. We analyze if this massive tender offer is a bold bet on its AI future or a retreat from growth.

Long-term shareholder Phoenix Asset Management publicly pressures UK homebuilder Barratt Redrow to accelerate buybacks, citing deep undervaluation.

A slight dip in Neuberger Private Equity's NAV masks a flurry of strategic moves, from lucrative exits to aggressive buybacks, revealing a playbook for thriving in a disconnected market.

The FTSE 250 firm's recent deals in aerospace and finance showcase a savvy blueprint for liquidity, leveraging co-investments and continuation vehicles.

Ninepoint's new buyback for its split corp is a calculated move. We deconstruct the strategy and what it reveals about their confidence and market view.

Sunstone sells the Hyatt Regency SF to Blackstone for $279M, a deal signaling a strategic shift for the REIT and a major bet on the city's comeback.

HLS Therapeutics is betting on itself with a larger share buyback. We analyze if this is a signal of deep value or a sign of limited growth opportunities.

A DKK 0.7B charge tests Alm. Brand, but a closer look reveals a masterclass in strategic capital management and resilient underlying growth.